| Literature DB >> 32930869 |
Jacob I Ayers1, David R Borchelt2.
Abstract
In many types of familial amyotrophic lateral sclerosis (fALS), mutations cause proteins to gain toxic properties that mediate neurodegenerative processes. It is becoming increasingly clear that the proteins involved in ALS, and those responsible for a host of other neurodegenerative diseases, share many characteristics with a growing number of prion diseases. ALS is a heterogenous disease in which the majority of cases are sporadic in their etiology. Studies investigating the inherited forms of the disease are now beginning to provide evidence that some of this heterogeneity may be due to the existence of distinct conformations that ALS-linked proteins can adopt to produce the equivalent of prion strains. In this review, we discuss the in vitro and in vivo evidence that has been generated to better understand the characteristics of these proteins and how their tertiary structure may impact the disease phenotype.Entities:
Keywords: Amyotrophic lateral sclerosis; Prion; Strains; Superoxide dismutase-1; TDP-43
Mesh:
Substances:
Year: 2020 PMID: 32930869 PMCID: PMC7956917 DOI: 10.1007/s00401-020-02222-x
Source DB: PubMed Journal: Acta Neuropathol ISSN: 0001-6322 Impact factor: 15.887